These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29029467)

  • 1. NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.
    Mangia A; Scarpi E; Partipilo G; Schirosi L; Opinto G; Giotta F; Simone G
    Oncotarget; 2017 Sep; 8(39):65730-65742. PubMed ID: 29029467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.
    Partipilo G; Simone G; Scattone A; Scarpi E; Azzariti A; Mangia A
    Int J Cancer; 2016 Jan; 138(1):110-20. PubMed ID: 26205471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
    Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
    Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
    Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
    J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
    Zhai L; Li S; Li H; Zheng Y; Lang R; Fan Y; Gu F; Guo X; Zhang X; Fu L
    Int J Clin Exp Pathol; 2015; 8(6):7059-71. PubMed ID: 26261599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients.
    Schirosi L; Saponaro C; Giotta F; Popescu O; Pastena MI; Scarpi E; Mangia A
    Transl Oncol; 2020 Feb; 13(2):186-192. PubMed ID: 31865181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical significance of PARP1 protein expression in breast cancer.
    Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
    Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
    Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity.
    Zhai L; Li S; Li X; Li H; Gu F; Guo X; Liu F; Zhang X; Fu L
    Pathol Res Pract; 2015 Feb; 211(2):130-7. PubMed ID: 25480692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprofile from tissue microarrays to stratify familial breast cancer patients.
    Schirosi L; De Summa S; Tommasi S; Paradiso A; Sambiasi D; Popescu O; Simone G; Mangia A
    Oncotarget; 2015 Sep; 6(29):27865-79. PubMed ID: 26312763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients.
    Saponaro C; Scarpi E; Zito FA; Giotta F; Silvestris N; Mangia A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
    Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
    Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
    Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological role of NHERF1 protein expression in breast cancer.
    Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A
    Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.
    Park SH; Noh SJ; Kim KM; Bae JS; Kwon KS; Jung SH; Kim JR; Lee H; Chung MJ; Moon WS; Kang MJ; Jang KY
    Transl Oncol; 2015 Aug; 8(4):239-49. PubMed ID: 26310369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer.
    Mangia A; Partipilo G; Schirosi L; Saponaro C; Galetta D; Catino A; Scattone A; Simone G
    Mol Biotechnol; 2015 Jun; 57(6):549-57. PubMed ID: 25744438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
    Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune response to PARP and BRCA1/BRCA2 in cancer.
    Zhu Q; Han SX; Zhou CY; Cai MJ; Dai LP; Zhang JY
    Oncotarget; 2015 May; 6(13):11575-84. PubMed ID: 25865228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.